These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3280467)

  • 61. The T-cell receptor recognizes nominal and self antigen independently. A theoretical alternative to the modified self concept.
    Hoffmann MK; Chun M; Hirst JA; Hämmerling U
    Curr Top Microbiol Immunol; 1986; 126():231-8. PubMed ID: 3087706
    [No Abstract]   [Full Text] [Related]  

  • 62. T cells with two functional antigen-specific receptors.
    Hardardottir F; Baron JL; Janeway CA
    Proc Natl Acad Sci U S A; 1995 Jan; 92(2):354-8. PubMed ID: 7530361
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection.
    Speiser DE; Kyburz D; Stübi U; Hengartner H; Zinkernagel RM
    J Immunol; 1992 Aug; 149(3):972-80. PubMed ID: 1634779
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antigen recognition by H-2-restricted cytolytic T lymphocytes is not mediated by two independent receptors.
    Harris DT; MacDonald HR; Cerottini JC
    J Exp Med; 1984 Jan; 159(1):330-5. PubMed ID: 6198426
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization of a product of histoincompatible spleen cells restoring class I-inhibited mixed-lymphocyte culture reactions.
    Ramseier H
    Cell Immunol; 1987 Nov; 110(1):107-19. PubMed ID: 2960457
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The mechanism of antigen presentation by dendritic cells and splenic adherent cells in the induction of an allogeneic cytotoxic T-lymphocyte response to H-2Kk liposomes.
    Greenstein JL; Herrmann SH; Sunshine GH; Burakoff SJ
    Cell Immunol; 1986 Jul; 100(2):389-99. PubMed ID: 2944605
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Activation of polyphosphoinositide hydrolysis in T cells by H-2 alloantigen but not MLS determinants.
    O'Rourke AM; Mescher MF; Webb SR
    Science; 1990 Jul; 249(4965):171-4. PubMed ID: 2164711
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ontogeny of diversity in the receptor repertoire of murine cytotoxic lymphocytes. I. Comparison of recognition patterns of activated T cells of B10.D2 and B10.BR mice of different ages and analysis of changes in F1 hybrid and bone marrow radiation chimeras.
    Gorczynski RM; Kennedy M; MacRae S
    Cell Immunol; 1982 Oct; 73(1):44-58. PubMed ID: 6185241
    [No Abstract]   [Full Text] [Related]  

  • 69. Nonconventional (TL-encoded) major histocompatibility complex molecules present processed viral antigen to cytotoxic T lymphocytes.
    Milligan GN; Flaherty L; Braciale VL; Braciale TJ
    J Exp Med; 1991 Jul; 174(1):133-8. PubMed ID: 1905336
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The requirements for antigen multivalency in class I antigen recognition and triggering of primed precursor cytolytic T lymphocytes.
    Herrmann SH; Mescher MF
    J Immunol; 1986 Apr; 136(8):2816-25. PubMed ID: 3082973
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunoselection of structural H-2Kb variants: use of cloned cytolytic T cells to select for loss of a CTL-defined allodeterminant.
    Sheil JM; Bevan MJ; Sherman LA
    Immunogenetics; 1986; 23(1):52-9. PubMed ID: 3484723
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Target sites for antibodies and cytotoxic T lymphocytes on H-2 molecules.
    Rüsch E; Kuon W; Hämmerling GJ
    Transplant Proc; 1983 Dec; 15(4):2093-6. PubMed ID: 6200977
    [No Abstract]   [Full Text] [Related]  

  • 73. Allospecific cytotoxic T lymphocytes recognize an H-2 peptide in the context of a murine major histocompatibility complex class I molecule.
    Song ES; Linsk R; Olson CA; McMillan M; Goodenow RS
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1927-31. PubMed ID: 3258067
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A nondeletional mechanism of peripheral tolerance in T-cell receptor transgenic mice.
    Morahan G; Hoffmann MW; Miller JF
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11421-5. PubMed ID: 1662395
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Neonatal tolerance to MIs-1a determinants: deletion or anergy of V beta 6+ T lymphocytes depending upon MHC compatibility of neonatally injected cells.
    Speiser DE; Brändle R; Lees RK; Schneider R; Zinkernagel RM; MacDonald HR
    Int Immunol; 1991 Feb; 3(2):127-34. PubMed ID: 1709047
    [TBL] [Abstract][Full Text] [Related]  

  • 76. MHC epitopes of KS and Dd restrict the same population of cytolytic T lymphocytes.
    Tyler JD; David CS
    Immunogenetics; 1983; 17(5):457-64. PubMed ID: 6188687
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The influence of self-MHC and non-MHC antigens on the selection of an antigen-specific T cell receptor repertoire.
    Fry AM; Cotterman MM; Matis LA
    J Immunol; 1989 Oct; 143(8):2723-9. PubMed ID: 2477456
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Generation of the alloreactive T cell repertoire: K region homology between H-2b T cell precursors and T cell maturation environment is required for the generation of the Kbm6-specific cytotoxic T cell repertoire.
    Gress RE; Hodes RJ
    J Immunol; 1984 May; 132(5):2226-31. PubMed ID: 6201535
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cytotoxic T lymphocytes recognize tumor antigens of a murine colonic carcinoma by using different T-cell receptors.
    Rodolfo M; Castelli C; Bassi C; Accornero P; Sensi M; Parmiani G
    Int J Cancer; 1994 May; 57(3):440-7. PubMed ID: 8169008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.